ScreenerHero

VOX Voxel S.A.

GPW · PL · Healthcare · Diagnostics & Research · voxel.pl
144.80PLN+2.26%Mkt Cap: 385.15M $P/E: 13.02

Voxel S.A. provides medical services in Poland. The company offers imaging diagnostics services, including reimbursed, commercial, and private patient examinations; teleradiology services; and clinical/pharmaceutical tri…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$250.23BUSDP/E 36.4
DHR
Danaher Corporation
$155.51BUSDP/E 39.4
NTRA
Natera, Inc.
$61.35BUSD
LONN
Lonza Group AG
$45.82BUSDP/E 38.1
A
Agilent Technologies, Inc.
$48.29BUSDP/E 33.8
ILMN
Illumina, Inc.
$44.35BUSDP/E 54.8
IQV
IQVIA Holdings Inc.
$43.80BUSDP/E 33.1
WAT
Waters Corporation
$43.21BUSDP/E 111.4
IDXX
IDEXX Laboratories, Inc.
$41.58BUSDP/E 37.0
MTD
Mettler-Toledo International Inc.
$30.89BUSDP/E 34.7
DGX
Quest Diagnostics Incorporated
$25.63BUSDP/E 24.7
GH
Guardant Health, Inc.
$25.12BUSD
LH
Labcorp Holdings Inc.
$25.03BUSDP/E 25.5
RVTY
Revvity, Inc.
$17.56BUSDP/E 75.3
MEDP
Medpace Holdings, Inc.
$17.32BUSDP/E 36.4
CRL
Charles River Laboratories International, Inc.
$14.84BUSD
ERF
Eurofins Scientific SE
$14.05BUSDP/E 26.2
ICLR
ICON Public Limited Company
$12.99BUSDP/E 177.2
BIM
bioMérieux S.A.
$10.02BUSDP/E 20.0
QGEN
Qiagen N.V.
$9.46BUSDP/E 23.2

Key Statistics

Company
Market Cap385.15M USD
Enterprise Value409.83M USD
Revenue (TTM)162.24M USD
Gross Profit42.53M USD
Net Income (TTM)24.95M USD
Revenue/Share61.00 PLN
Last Price144.80 PLN
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees356
CountryPL
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)13.02
P/E (Forward)14.47
PEG—
EV/EBITDA8.35
EV/Revenue2.53
P/S2.32
P/B3.38
EPS (TTM)11.12
EPS (Forward)—
52W Range
93.8062% of range176.00
52W High176.00 PLN
52W Low93.80 PLN
Profitability
Gross Margin28.77%
Oper. Margin24.08%
EBITDA Margin30.26%
Profit Margin16.88%
ROE24.10%
ROA13.94%
Growth
Revenue Growth45.10%
Earnings Growth49.00%
Cash Flow & Leverage
Operating CF29.55M USD
CapEx (TTM)19.20M USD
FCF Margin7.75%
FCF Yield3.26%
Net Debt31.35M USD
Net Debt/EBITDA0.64
Balance Sheet
Debt/Equity0.45
Current Ratio1.52
Quick Ratio1.22
Book Value/Sh41.90 PLN
Cash/Share3.32 PLN
Dividends
Fwd Div Rate2.50 PLN
Trail. Div Rate2.50 PLN
Div. Yield1.77%
5Y Avg Yield3.25%
Payout Ratio42.99%
Ex-Div DateSep 29, 2026
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)153.07 PLN
Upside (mean)+5.7%
Target Range143.40 PLN – 161.50 PLN
143.40+5.7% to mean161.50
# Analysts3
Ownership
Shares Out.10.50M
Float5.04M
Insiders37.43%
Institutions31.44%
Technical
SMA 50135.79 (+6.6%)
SMA 200122.34 (+18.4%)
Beta0.58
S&P 52W Chg14.58%
Avg Vol (30d)9.92K
Avg Vol (10d)7.88K
Technical Indicators
RSI (14)56.9
MACD2.4125
MACD Signal3.2062
MACD Hist.-0.7937
BB Upper149.41 PLN
BB Middle144.08 PLN
BB Lower138.75 PLN
BB Width7.40%
ATR (14)4.180 PLN
Vol Ratio (20d)0.77x